| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/08/1999 | CA2282458A1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/08/1999 | CA2281938A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | CA2240798A1 Method for induction of differentiation of osteoclasts |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927252A1 Antibodies against interferon alpha/beta receptor |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927196A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927184A1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927178A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927163A1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927159A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927062A1 Skin battery cosmetic composition |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |
| 07/07/1999 | EP0927039A1 Induction of a cellular stress response with heavy metal salts |
| 07/07/1999 | EP0927033A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 07/07/1999 | EP0927030A1 Use of aryl n-substituted carboxamides to kill tumors |
| 07/07/1999 | EP0636027B1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 07/07/1999 | EP0587799B1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 07/07/1999 | EP0537166B1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222077A Fase-dissolving galanthamine hydrobromide tablet |
| 07/07/1999 | CN1221743A Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 07/07/1999 | CN1221734A New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/07/1999 | CN1221608A Synergistic combination of AIDS antiviral compounds and HIV inhibitor |
| 07/07/1999 | CN1043994C Thionaphthene diazepine compound, its prodn. method and application |
| 07/07/1999 | CN1043992C Process for prepn. of indolizine derivatives |
| 07/07/1999 | CN1043991C Qunazoline derivatives |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919936 Nitropyridine compound |
| 07/06/1999 | US5919923 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 07/06/1999 | US5919829 Gastrin and cck receptor ligands |
| 07/06/1999 | US5919818 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 07/06/1999 | US5919816 Administering drug with protective agent |
| 07/06/1999 | US5919814 Heterocyclic compounds |
| 07/06/1999 | US5919811 Neurodegenerative disorders |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919809 3-substituted-2-oxindole derivatives |
| 07/06/1999 | US5919805 Hetrocyclic compounds and their preparation and use |
| 07/06/1999 | US5919803 3-benzylamino-2-phenylpiperidines as neurokinin antagonists |
| 07/06/1999 | US5919802 Methods of preventing and/or treating temporal lobe epilepsy |
| 07/06/1999 | US5919801 N-substituted piperidines as PDE4 inhibitors |
| 07/06/1999 | US5919791 Ellipticine compounds |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919787 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 07/06/1999 | US5919778 Alzheimer*s disease |
| 07/06/1999 | US5919775 Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
| 07/06/1999 | US5919774 Novel compounds such as 2-(1-benzyl-2,5-dimethyl-4-(2-carboxyphenylmethyl)pyrrol-3-yl) glyoxamide for inhibiting human nonpancreatic secretory phospholipase a2 (spla2) mediated release of fatty acids in a mammal |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919687 Polynucleotide coding for neutral sphingomyelinase; for screening compounds for diagnosis and treatment of diseases; antiarthritic/antitumor/anticarcinogenic/anticholesterol agents; psychological/nervous system disorders |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919659 Polynucleotide |
| 07/06/1999 | US5919438 Combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside |
| 07/06/1999 | CA2177146C Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 07/06/1999 | CA2157397C Indole derivatives as 5-ht1-like agonists for use in migraine |
| 07/06/1999 | CA2131991C Treatment of migraine |
| 07/06/1999 | CA2130762C Treatment of disease and conditions associated with macrophage infiltration |
| 07/06/1999 | CA2017920C Beta-lactam elastase inhibitors |
| 07/05/1999 | WO1999038976A2 Human growth factor homologs |
| 07/05/1999 | CA2317812A1 Human growth factor homologs |
| 07/01/1999 | WO1999032637A1 Human signal transduction serine/threonine kinase |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032506A1 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES |
| 07/01/1999 | WO1999032483A1 New pharmaceutically active compounds |
| 07/01/1999 | WO1999032480A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 07/01/1999 | WO1999032477A1 Ortho-anthranilamide derivatives as anti-coagulants |
| 07/01/1999 | WO1999032476A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032475A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032463A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 07/01/1999 | WO1999032461A1 1,4-diazacycloheptane derivatives |
| 07/01/1999 | WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 07/01/1999 | WO1999032457A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 07/01/1999 | WO1999032456A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032455A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 07/01/1999 | WO1999032453A1 POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032449A2 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032448A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 07/01/1999 | WO1999032437A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof |
| 07/01/1999 | WO1999032436A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 07/01/1999 | WO1999032433A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 07/01/1999 | WO1999032150A1 Ace inhibitor-mmp inhibitor combinations |
| 07/01/1999 | WO1999032148A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | WO1999032144A1 Method for preventing/remedying mastitis |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999032129A1 Ginkgo biloba leaf extracts with a reduced 4'-o-methylpyridoxine and biflavone content |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 07/01/1999 | WO1999032125A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 07/01/1999 | WO1999032121A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| 07/01/1999 | WO1999032119A1 Opioid agonist/antagonist combinations |